Pfizer to acquire livestock DNA companies

21-03-2008 | |
Pfizer to acquire livestock DNA companies

Pfizer Animal Health announced in a press release on Tuesday that it will acquire two market-leading livestock genomics companies.

Firstly, it will acquire Catapult Genetics, Pty., Ltd., focused on developing and commercialising innovative livestock DNA tests and gene markers to assist global food producers, processors and retailers in improving profitability and quality in the global food chain; and

In addition, Bovigen, LLC, which markets DNA technology, including Catapult’s products in the US and throughout Canada, Central America and South America will join its portfolio.

Terms of the agreements were not disclosed. The acquisitions are expected to close by the end of this month. The two companies will continue to market products and services to their own customers as well as Pfizer Animal Health customers.

“This is a strategic initiative that places Pfizer at the forefront of livestock gene marker R&D and enhances Pfizer’s ability to offer more complete solutions to global livestock producers,” said Juan Ramon Alaix, president, Pfizer Animal Health.

Gerard Davis, chief executive officer, Catapult Genetics commented that he expects livestock producers will begin to see an enhanced range of genetic tools. “

Pfizer will continue to access and draw on the best R&D from Australia, New Zealand, the U.S., and Europe. As novel marker panels are discovered and developed, Pfizer plans to introduce new products and services to livestock producers.

About Catapult Genetics
Catapult is a global innovator and leader in livestock DNA testing technologies for meat and carcass quality and production efficiency under the GeneSTAR® Quality Grade, Feed Efficiency, the SureTRAK® system, and the SireTRACETM product brands.

About Bovigen
Bovigen, LLC, based in Harahan, Louisiana, is a global genetic technology company founded by Vic Castellon in 2003. Bovigen will continue to market and service Catapult’s products throughout the Americas.

About Pfizer Animal Health
Pfizer Inc. (NYSE: PFE), the world’s largest research-based pharmaceutical company, is a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Animal Health is dedicated to improving the safety, quality and productivity of the world’s food supply by enhancing the health of livestock and poultry; and in helping companion animals live longer and healthier lives.

For the latest pig news, subscribe here